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Teixeira et al. show that cyclin E
deregulation causes cells to enter into
mitosis with incompletely replicated
genomes, leading to chromosome
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loci. Their study demonstrates how
oncogene-induced replication stress
contributes to genomic instability in
human cancer.
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Cell-cycle progression is regulated by the cyclin-
dependent kinase (Cdk) family of protein kinases,
so named because their activation depends on
association with regulatory subunits known as
cyclins [1]. Cyclin E normally accumulates at the
G1/S boundary, where it promotes S phase entry
and progression by activating Cdk2. In normal
cells, cyclin E/Cdk2 activity is associated with
DNA replication-related functions [2]. However,
deregulation of cyclin E leads to inefficient assem-
bly of pre-replication complexes [3], replication
stress [4], and chromosome instability [5]. In ma-
lignant cells, cyclin E is frequently overexpressed,
correlating with decreased survival in breast
cancer patients [6, 7]. Transgenic mice deregu-
lated for cyclin E in the mammary epithelia
develop carcinoma [8], confirming that cyclin E is
an oncoprotein. However, it remains unknown
how cyclin E-mediated replication stress promotes
genomic instability during carcinogenesis. Here,
we show that deregulation of cyclin E causes
human mammary epithelial cells to enter into
mitosis with short unreplicated genomic segments
at a small number of specific loci, leading to
anaphase anomalies and ultimately deletions.
Incompletely replicated regions are preferentially
located at late-replicating domains, fragile sites,
and breakpoints, including the mixed-lineage leu-
kemia breakpoint cluster region (MLL BCR).
Furthermore, these regions are characterized by
a paucity of replication origins or unusual DNA
structures. Analysis of a large set of breast tumors
shows a significant correlation between cyclin E
amplification and deletions at a number of the
genomic loci identified in our study. Our results
demonstrate how oncogene-induced replication
stress contributes to genomic instability in human
cancer.Current Biology 25, 132RESULTS
Ongoing DNA Replication in Mitotic Cells
Cyclin E-mediated replication stress results in depressed origin
firing [9], slowed fork progression [10], and aberrant fork archi-
tecture [11]. However, the molecular mechanisms that link repli-
cation stress to genomic instability remain poorly understood.
We hypothesized that cyclin E deregulation expands the time in-
terval required for DNA replication, causing cells to enter into
mitosis with incompletely replicated genomes. To test this
idea, we used recombinant cyclin E-expressing adenoviruses
to increase cyclin E levels in immortalized human mammary
epithelial cells (HME1) (Figure 1A). MDA-MB-157 [12] and
SUM149PT [13], breast cancer-derived cell lines that overex-
press cyclin E, were used as controls. Transduction multiplicities
that recapitulated cyclin E levels observed in the high cyclin E
breast cancer cell lines (Figure 1A) were used in all subsequent
experiments. To compare the rate of S phase progression in cells
deregulated for cyclin E expression and controls, we transduced
HME1 cells with cyclin E and control viruses and released from a
double-thymidine block for 8 hr (Figure 1B). Flow cytometric
analysis revealed that cyclin E deregulation reduced the rate of
progression through S phase (control = 20% versus cyclin
E = 62% remaining in S phase after 8 hr). Cells expressing de-
regulated cyclin E required 12–16 hr to complete S phase (Fig-
ure S1A). To determine whether cells could enter into mitosis
with ongoing replication, we used strong phosphorylation of his-
tone H3 on serine 10 as a marker for late G2/M phase, while
ongoing replication was scored by incorporation of BrdU during
a short pulse (Figures S1B and S1C). A significant fraction of
cyclin E-deregulated cells that stained strongly positive for
phospho-H3 also stained positive for BrdU incorporation (cyclin
E = 16.4%, n = 286; Figures 1C and 1D). However, double-
positive cells were completely absent in controls (n = 526; Fig-
ure 1D). Increased transduction multiplicities correlated with
higher frequencies of double-positive cells, reaching almost
50% of the total (Figure 1E). These data indicate that a fraction
of cells experiencing cyclin E deregulation are near or in mitosis
while DNA replication is ongoing.Cyclin E Deregulation Causes Aberrant Anaphases
Persistence of unreplicated DNA into mitosis is expected
to cause abnormalities during chromosome segregation. We7–1333, May 18, 2015 ª2015 Elsevier Ltd All rights reserved 1327
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Figure 1. OngoingDNADuplication inMitosis
upon Cyclin E Deregulation
(A) Immunoblot analysis of HME1, MDA-MB-157,
and SUM149PT cells. HME1 cells were transduced
with control adenovirus () or increasing amounts
of cyclin E adenovirus (1–10 3 103 particles per
cell). Upper blot: short exposure; lower blot: long
exposure.
(B) Flow cytometry analysis of HME1 cells trans-
duced as in (A), synchronized with a double-thymi-
dine block protocol, and released for 8 hr.
(C) Immunofluorescence of HME1 cells treated as in
(B) and pulsed with BrdU for 10 min 8 hr after
release.
(D and E) Frequency of double-positive cells
(phospho-H3+ and BrdU+) transduced and treated
as in (B) (D) or transduced with increasing amounts
of cyclin E (1–10 3 103 particles per cell) (E).
Results are representative of at least three inde-
pendent experiments. Error bars represent 1 SD.
The scale bar represents 5 mm. See also Figure S1.therefore screened cyclin E-deregulated HME1 cells for aberrant
mitotic chromosome dynamics by live-cell microscopy (Fig-
ure 2A). Cyclin E deregulation caused a 3.2-fold increase in
abnormal metaphase-to-telophase transitions (control = 16.3%
versus cyclin E = 53.2%; n > 100, p = 2.9 3 105, unpaired
t test; Figure 2B), including the formation of anaphase bridges,
lagging chromosomes, and micronuclei (AB, p = 0.0037; LC,
p = 0.0009; MN, p = 0.0025, unpaired t test; Figure S2A; Movies
S1 and S2). These abnormal anaphases are consistent with
attempted chromosome segregation in the presence of incom-
pletely replicated DNA [14–16].
Cyclin E Causes Replication Failure at a Limited Number
of Specific Genomic Loci
To determine whether specific loci are incompletely replicated in
mitotic cells after one cell cycle during which cyclin E was de-
regulated, we carried out comparative genome hybridization
(CGH) array analysis on DNA from prometaphase cells that
were first synchronized by a double-thymidine block and
released into nocodazole (see Supplemental Experimental Pro-
cedures). CGH arrays indicated 20-fold more underreplicated
chromosomal segments than overreplicated segments upon
cyclin E deregulation (8,334 versus 341 probes in at least one
sample; Figure S3A and Table S1). We then focused on chromo-
somal segments that were scored as underreplicated in at least
two of the three experiments and were detected by at least five
contiguous probes. Surprisingly, decreased signals, indicating
underreplication, were concentrated at only 16 genomic loci
distributed over many chromosomes and varied in size from a
few kb to over 100 kb (Table 1 and Figure S3B). These loci
were frequently, but not always, located in late-replicating do-
mains based on replication timing of IMR-90 human fibroblasts
(Table 1) [17]. Furthermore, some loci were located in pericentro-
meric or subtelomeric regions, as well as fragile sites and break-
point or recombination hotspots (Table 1) [18]. Note that one of
the sites encompasses the breakpoint cluster region of the1328 Current Biology 25, 1327–1333, May 18, 2015 ª2015 Elsevier Lmixed-lineage leukemia gene (mixed-lineage leukemia break-
point cluster region [MLL BCR]; Table 1 and Table S1), often
rearranged in leukemias [19] but also deleted in breast cancer
(see below).
To determine whether underreplication after one pulse of
cyclin E correlates with eventual genomic loss in proliferating
populations, we transducedHME1cells twice aweek for 3weeks
with control or cyclin E adenovirus, after which average copy
number at eight loci that exhibited underreplication in the popu-
lation was interrogated by real-time PCR (Figure 2C). Significant
genomic losses were detected for six of the eight loci analyzed,
with signal decreases varying from 12% to 17%, confirming a
link between cyclin E-mediated underreplication and subse-
quent genomic loss. For a heterogeneous diploid cell population,
a signal decrease of 15% indicates that one in every three cells
has experienced a deletion at the interrogated locus.
To determine the frequency of cells experiencing genomic los-
ses at specific loci, we analyzed single cells for deletion at three
loci by real-time PCR. HME1 cells were transduced twice with
control or cyclin E adenovirus, and individual cells were isolated
by fluorescence-activated cell sorting (FACS). Genomes from
eight control and nine cyclin E cells were amplified and analyzed
for deletions at loci 2, 3, and 14 (Figures 2D–2F). Deletions were
detected in one of the nine cyclin E cells at locus 2 (cell E1, Fig-
ure 2D) and two of the nine cyclin E cells at loci 3 and 14, respec-
tively (cells E7 and E8, Figure 2E; cells E2 and E8, Figure 2F). The
occurrence of five deletions at three loci for nine cyclin E cells
compared to none for eight control cells was significant (p =
0.032, Fisher’s exact test).
Cyclin E Deregulation Causes Loss of the MLL BCR
Locus
We then specifically addressed deletion at the MLL BCR locus
by fluorescence in situ hybridization (FISH) (Figure 2G). Cyclin
E deregulation caused an almost 3-fold increase in aberrant
FISH signals at this locus (control = 1.77% versus cyclintd All rights reserved
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Figure 2. Cyclin E Deregulation Causes Loss of MLL BCR Locus and Chromosome Aberrations in Mitosis
(A) Laser scanning confocal microscopy of live HME1 cells expressing GFP-H2B and transduced with control (Adv-Control) or cyclin E adenovirus (Adv-Cyclin E).
(B) Frequency of normal and abnormal metaphase-to-anaphase transitions in HME1 cells transduced with control (white bars) or cyclin E adenovirus (black bars).
(C) Real-time PCR analysis of eight genomic loci. HME1 cells were transduced with control (black bars) or cyclin E adenovirus (white bars) twice a week
for 3 weeks.
(D–F) Real-time PCR analysis of three genomic loci in individual cells. HME1 cells were transduced twice with control (C) or cyclin E adenovirus (E), individually
isolated using a FACS, processed for whole-genome amplification, and analyzed for loci 2 (D), 3 (E), and 14 (F). CTL indicates themean of the eight control clones.
Error bars for individual genomes correspond to PCR quadruplicate reactions.
(G) FISH analysis of MLL BCR locus in HME1 cells transduced with control or cyclin E adenovirus. Probes are located to the N terminus (green signal) or
C terminus (red signal) of the MLL BCR.
(H) Frequency of abnormal FISH signals in HME1 cells transduced with control (white bars) or cyclin E adenovirus (black bars).
(I) Frequency of abnormal FISH signals at theMLL BCR locus in HME1 cells transduced with control (white bars) or cyclin E adenovirus (black bars). R, red probe;
G, green probe; MN, micronucleus; TL, translocation; NS, no signal.
All results are representative of at least two independent experiments. All error bars represent 1 SD. Asterisks indicate significance levels compared to control
samples (*p < 0.05; **p < 0.005). Scale bars represent 5 mm. See also Figure S2 and Movies S1 and S2.E= 5.11%; n > 5,000 cells, p = 0.0104, unpaired t test; Figure 2H).
The primary signal differences observed were loss of the distal
region (1R/2G = loss of one red signal; control = 0.153% versus
cyclin E = 1.147%, p = 0.0040, unpaired t test; Figure 2I) and the
loss of one entire copy of the locus through micronucleus forma-
tion (MN, control = 0.034%versus cyclin E = 0.269%, p = 0.0231,
unpaired t test; Figure 2I). These data are consistent with persis-
tence of unreplicated DNA during mitosis, leading to chromo-
some breaks and subsequent loss of genetic material [14–16].Current Biology 25, 132Consistent with this, a recent study showed that cyclin E dereg-
ulation frequently causes deletion ofmost or all of the right arm of
chromosome 3 [20], which contains several of the loci identified
in this study.
Origin Paucity Correlates with Genomic Loss
One feature of genomic regions that are sensitive to replication
stress is paucity of replication origins, which forces DNA replica-
tion forks to travel long distances, increasing the probability of7–1333, May 18, 2015 ª2015 Elsevier Ltd All rights reserved 1329
Table 1. Analysis of DNA Underreplication in Mitotic Cells with Deregulated Cyclin E
Locus Chrom Region Size (bp)
Inferred Copy
Number
Replication
Timing Location Fragile Site
Breakpoint/
Recombination Gene
1 3 3p26.1 7,396 0.1029 late subtelomeric
2 3 3q11.2 102,906 0.0956 late pericentromeric EPHA6
3 3 3q26.1 14,758 0.0973 late large LRD (9 Mb)
4 3 3q26.1 35,313 0.1146 late large LRD (9 Mb)
5 3 3q29 2,636 0.1930 late subtelomeric breakpoint
6 11 11q23.3 4,331 0.1617 early ERD (1.5 Mb) FRA11B/G MLL
7 16 16q21 4,100 0.1067 late large LRD (7 Mb)
8 17 17q21.2 228 0.3222 early large ERD (15 Mb) breakpoint
9 18 18p11.21 48,333 0.0995 late pericentromeric ANKRD30B
10 18 18q21.2-
q21.31
13,443 0.1449 early ERD (1.5 Mb) FRA18B recombination hotspot
11 18 18q22.1 18,363 0.1136 late LRD (3.5 Mb) FRA18C breakpoint
12 21 21q21.1 11,690 0.1346 late large LRD (9.5 Mb) breakpoint
13 21 21q21.1 8,809 0.1153 late large LRD (9.5 Mb) NCAM2
14 21 21q21.1 56,443 0.1105 late large LRD (9.5 Mb) recombination hotspot MAPK6PS2
15 21 21q21.2 72,026 0.0951 late large LRD (9.5 Mb) recombination hotspot
16 22 22q12.3 56,452 0.0772 late late-replicating island
Sources include UCSC Genome Browser, Assembly NCBI Build 36.1/hg18; Database of Genomic Variants, The Center for Applied Genomics, Build
36; and Replication Domain Database, The Florida State University. Chrom, chromosome; LRD, late-replicating domain; ERD, early-replicating
domain. See also Figure S3 and Table S1.fork collapse [21], and which also reduces the likelihood of
rescue by adjacent forks [22]. We therefore addressed DNA
replication origin (ORI) density at the 16 genomic loci found
underreplicated in CGH experiments using two databases of hu-
man genome-wide origin distribution [23, 24] (Figures 3A and
S2B). It is noteworthy that ORI mapping data in mammalian cells
have been characterized by low reproducibility. However, anal-
ysis of a 1-Mb region surrounding each locus showed that
many of the loci are located in origin-poor regions (locus # 2, 3,
4, 7, 9–15; Figure 3A), and the total number of ORIs in the
1-Mb neighborhoods surrounding the 16 genomic loci is
significantly lower than the total number of ORIs in the 1-Mb
neighborhoods of 16 randomly selected genomic locations
(94 versus 161 ORIs [23]; p < 0.025, permutation-based enrich-
ment test; Table S2). Remarkably, among the 16 genomic
loci, seven are located R400 kb away from the closest ORI,
including four loci that are more than 600 kb from the closest
ORI (locus # 3, 11, 12, and 14; Table S2). In comparison, only 3
out of 16 randomly selected genomic loci are locatedR400 kb
away from the closest ORI [23]. Although these data are only
correlative and not derived from HME1 cells, they suggest that
paucity of replication origins may contribute to the replication
impairment and eventual loss of specific regions in response to
cyclin E deregulation.
Unusual DNA Structures Can Contribute to Cyclin
E-Mediated Genomic Loss
Another feature of regions that are sensitive to replication stress
is DNA sequences that are predicted to form stem-loops [25].
The MLL BCR, identified in our study, is not in an origin-poor
or late-replicating region. However, analysis of DNA folding of
the MLL BCR N terminus, underreplicated in our CGH experi-1330 Current Biology 25, 1327–1333, May 18, 2015 ª2015 Elsevier Lments, showed two putative stem-loop structures located in in-
trons 7 and 8: DG = 7.15 kcal and 9.69 kcal, respectively
(Figures S2C and S2D). The stem-loop structures consist of
94 bp and 67 bp, respectively, and are separated by approxi-
mately 500 bp. To test the idea that cyclin E deregulation pro-
motes deletions by impairing replication of such structures, we
cloned part of the MLL BCR N terminus containing the two
stem-loop structures into the episomal plasmid pCEP4 (Fig-
ure 3B; see Supplemental Experimental Procedures). As a
control, the same sequence missing the stem-loops was in-
serted into the vector. Cyclin E deregulation had no effect on
the control plasmid but conferred a dose-dependent impairment
of maintenance and transmission of the plasmid containing the
two stem-loop-forming structures, asmeasured by relative num-
ber of hygromycin-resistant cells (low cyclin E, p = 0.012; high
cyclin E, p = 9.7 3 105, unpaired t test; Figures 3C, S2E, and
S2F) or by relative replicated plasmid levels, as determined by
real-time PCR (p = 0.0019, unpaired t test; Figures 3D, S2G,
and S2H).
Cyclin E Amplification Correlates with Loss of Specific
Genomic Regions in Breast Cancer
We next evaluated the relevance of our in vitro findings to breast
cancer. CGH arrays from 1,962 primary fresh-frozen breast can-
cer specimens [18] were interrogated for association between
cyclin E1 amplification and copy number losses at the genomic
regions established in vitro by CGH (see Supplemental Experi-
mental Procedures). We observed a significant correlation be-
tween cyclin E1 gain and genomic region loss in 6 out of 16
analyzed loci (locus # 2, 3, 4, 11, 12, 14; p < 0.05, Fisher’s exact
test; Figure S3C). Furthermore, three additional loci (locus # 6, 7,
16; Figure S3C), including the N terminus of the MLL BCRtd All rights reserved
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Figure 3. Paucity of ORIs and Unusual DNA
Structures Underlies Cyclin E-Mediated
Genomic Loss
(A) Schematic representation of the 16 CNV loci
identified in this study along with the ORIs previ-
ously identified on human chromosomes [23]. The
black ticks mark the locations of the ORIs; the blue
triangles indicate the locations of the 16 loci; and
the red lines plot the estimated ORI probability
density (see Supplemental Experimental Pro-
cedures).
(B) Schematic representation of the MLL BCR N
terminus containing two putative stem-loop-form-
ing sequences (MLL BCR) or the same DNA
sequence lacking the two stem-loops (Control)
cloned into the pCEP4 plasmid. Diagrams are not
drawn to scale.
(C) Cell survival analysis in U2OS cells transfected
with pCEP4 plasmid encoding a fragment of the
MLL BCR N terminus (MLL BCR, black squares) or
a control fragment lacking the stem-loop structures
(Control, open circles). Cells were transduced with
control adenovirus () or increasing amounts of
cyclin E adenovirus (see Figure S2 for non-
normalized data and also Supplemental Experi-
mental Procedures).
(D) Real-time PCR analysis of DpnI-treated pCEP4
plasmids on day 0 (white bars) and day 10 (black
bars) containing part of the MLL BCR sequence
(MLL BCR) or a control sequence lacking the two
stem-loop-forming regions (Control). Data repre-
sent relative plasmid levels (Control or MLL BCR)
extracted from cyclin E-deregulated cells normalized to plasmid levels extracted from control cells (see Figure S2 for non-normalized data and also
Supplemental Experimental Procedures).
Results are representative of at least two independent experiments. Error bars represent 1 SD. Asterisks indicate significance of difference from control samples
(*p = 0.012; **p = 0.0019; ***p = 9.7 3 105). See also Figure S2 and Table S2.locus, were lost in more than 10% of breast cancer patients
(locus # 6 = 16.6%, n = 326 out of 1,962 [copy number variation
[CNV] patients per all patients]), even though these losses did not
correlate with cyclin E1 amplification (Figure S3C). It is therefore
likely that other mechanisms contribute to copy number losses
at these genomic loci, masking the effects of cyclin E1 over-
expression. Taken together, our data show that cyclin E deregu-
lation causes cells to enter into mitosis with incompletely
replicated genomes, leading to chromosome segregation anom-
alies and copy number losses originating at specific unreplicated
loci and thus contributing to the genomic instability observed in
breast cancer.
DISCUSSION
Oncogene expression has been linked to replication stress, lead-
ing to stalled replication forks, DNA damage, and, ultimately,
impaired progression through S phase [4, 26–30]. It has been
assumed that a cell-cycle checkpoint prevents cells with
expanded replication times from entering mitosis prior to
completion of DNA replication. However, in the case of cyclin
E deregulation, cells are not prevented from entering mitosis
with a small number of short unreplicated segments. These
data suggest that a minimal amount of unreplicated DNA is
required to trigger this checkpoint and that levels below a
threshold can evade surveillance [14, 31].Current Biology 25, 132It is not clear why a small select group of loci are particularly
sensitive to cyclin E-mediated replication failure. Nevertheless,
these loci appear to subdivide into two classes, suggesting
that at least two different mechanisms may be involved. The first
class, which includes most of the loci identified, is characterized
by location within late-replicating domains with a paucity of
replication origins. This suggests a mechanism whereby fork
collapse caused by cyclin E-mediated replication stress cannot
be repaired prior to mitotic entry because of late timing of origin
initiation and large inter-origin distances prohibiting rescue by
adjacent forks [32, 33]. However, not all origin-poor late-repli-
cating regions were identified in our study. It is therefore likely
that other properties of these regions contribute to their sensi-
tivity to cyclin E deregulation. One possible compounding factor
may be related to the observation that cyclin E overexpression
interferes with pre-replication complex assembly [3], exacer-
bating replication stress by preventing the formation of dormant
origins required to rescue collapsed forks [22]. Thus, it may be
that the cyclin E-sensitive loci identified in this study are partic-
ularly impaired in formation of dormant origins when cyclin E is
overexpressed.
The second class of loci, typified by the MLL BCR, might be
characterized by structured DNA that is likely to impose a barrier
to replication fork progression. The likely mechanism of replica-
tion failure is that cyclin E-mediated replication stress sensitizes
forks so that they tend to stall or collapse when they encounter7–1333, May 18, 2015 ª2015 Elsevier Ltd All rights reserved 1331
such structures. However, many such structures have been
identified in the genome [32, 34]. Yet, most of these were not
identified as cyclin E sensitive in the current study. Again, other
factors must contribute to sensitization by cyclin E overexpres-
sion. One possible explanation is that the MLL BCR contains
two predicted stem-loops within a short distance (500 bp). Inter-
estingly, one well-defined MLL breakpoint in intron 8 localizes at
the base of the putative stem-loop structure identified here,
which also contains a binding site for topoisomerase II and re-
combinase [35]. On the other hand, deletion of the MLL BCR in
breast cancer, which is quite frequent, did not correlate with
cyclin E amplification, suggesting that stem-loop structures are
sensitive to multiple forms of replication stress. Nevertheless, a
study of MLL rearrangements in leukemia patients identified
elevated cyclin E levels as a major driver [36], indicating that in
some cancers, cyclin E-mediated replication stress is critical
for damage at this locus.
Our findings suggest a mechanism for how replication stress
contributes to genomic instability in cancer. In particular, we
demonstrate a likely mechanism to explain specific genetic
losses that occur during mammary tumorigenesis mediated by
cyclin E deregulation. It will be interesting to determine whether
the same mechanisms apply in other cell types and cancers
driven by cyclin E, as well as other oncoproteins.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, two tables, and two movies and can be found with this article
online at http://dx.doi.org/10.1016/j.cub.2015.03.022.
AUTHOR CONTRIBUTIONS
L.K.T. and S.I.R. conceived the study and designed the experiments. L.K.T
performed and analyzed most cellular and molecular experiments. X. Wang
and P.W. analyzed CGH arrays and chromatin immunoprecipitation
sequencing data. Y.L. and X. Wu performed and analyzed plasmid retention
experiments. S.E.-R. and S.I.R. performed and analyzed single-cell genome
amplification experiments. S.I.R. supervised all aspects of the project. L.K.T.
and S.I.R. wrote the manuscript with contributions from all authors.
ACKNOWLEDGMENTS
We thank M. Henze, TSRI flow cytometry (particularly M. Haynes for help with
single-cell isolation), and microscope core facilities for assistance; J. Cogs-
well, S. Neill, and J. Albrecht for reagents; E. Denchi and J. Erwin for help
with FISH; and V. Liberal for comments. L.K.T. acknowledges support from
the Pew Latin American Fellows Program in the Biomedical Sciences. This
work was supported by NIH grants CA078343 to S.I.R., CA138215,
GM082802, CA160034, and CA138293 to P.W., and CA140972 and
CA102361 to X. Wu.
Received: July 31, 2014
Revised: February 24, 2015
Accepted: March 13, 2015
Published: May 7, 2015
REFERENCES
1. Malumbres, M., and Barbacid, M. (2009). Cell cycle, CDKs and cancer: a
changing paradigm. Nat. Rev. Cancer 9, 153–166.
2. Hwang, H.C., and Clurman, B.E. (2005). Cyclin E in normal and neoplastic
cell cycles. Oncogene 24, 2776–2786.1332 Current Biology 25, 1327–1333, May 18, 2015 ª2015 Elsevier L3. Ekholm-Reed, S., Me´ndez, J., Tedesco, D., Zetterberg, A., Stillman, B.,
and Reed, S.I. (2004). Deregulation of cyclin E in human cells interferes
with prereplication complex assembly. J. Cell Biol. 165, 789–800.
4. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva,
N., Vassiliou, L.V., Kolettas, E., Niforou, K., Zoumpourlis, V.C., et al. (2006).
Oncogene-induced senescence is part of the tumorigenesis barrier
imposed by DNA damage checkpoints. Nature 444, 633–637.
5. Spruck, C.H., Won, K.A., and Reed, S.I. (1999). Deregulated cyclin E in-
duces chromosome instability. Nature 401, 297–300.
6. Porter, P.L., Malone, K.E., Heagerty, P.J., Alexander, G.M., Gatti, L.A.,
Firpo, E.J., Daling, J.R., and Roberts, J.M. (1997). Expression of cell-cycle
regulators p27Kip1 and cyclin E, alone and in combination, correlate with
survival in young breast cancer patients. Nat. Med. 3, 222–225.
7. Keyomarsi, K., Tucker, S.L., Buchholz, T.A., Callister, M., Ding, Y.,
Hortobagyi, G.N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe,
M., et al. (2002). Cyclin E and survival in patients with breast cancer.
N. Engl. J. Med. 347, 1566–1575.
8. Bortner, D.M., and Rosenberg, M.P. (1997). Induction of mammary gland
hyperplasia and carcinomas in transgenic mice expressing human cyclin
E. Mol. Cell. Biol. 17, 453–459.
9. Liberal, V., Martinsson-Ahlze´n, H.-S., Liberal, J., Spruck, C.H.,
Widschwendter, M., McGowan, C.H., and Reed, S.I. (2012). Cyclin-
dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the
DNA damage response barrier triggered by activated oncoproteins.
Proc. Natl. Acad. Sci. USA 109, 2754–2759.
10. Bester, A.C., Roniger, M., Oren, Y.S., Im, M.M., Sarni, D., Chaoat, M.,
Bensimon, A., Zamir, G., Shewach, D.S., and Kerem, B. (2011).
Nucleotide deficiency promotes genomic instability in early stages of can-
cer development. Cell 145, 435–446.
11. Neelsen, K.J., Zanini, I.M., Herrador, R., and Lopes, M. (2013). Oncogenes
induce genotoxic stress by mitotic processing of unusual replication inter-
mediates. J. Cell Biol. 200, 699–708.
12. Keyomarsi, K., and Pardee, A.B. (1993). Redundant cyclin overexpression
and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA
90, 1112–1116.
13. Strohmaier, H., Spruck, C.H., Kaiser, P., Won, K.A., Sangfelt, O., and
Reed, S.I. (2001). Human F-box protein hCdc4 targets cyclin E for
proteolysis and is mutated in a breast cancer cell line. Nature 413,
316–322.
14. Chan, K.L., Palmai-Pallag, T., Ying, S., and Hickson, I.D. (2009).
Replication stress induces sister-chromatid bridging at fragile site loci in
mitosis. Nat. Cell Biol. 11, 753–760.
15. Naim, V., and Rosselli, F. (2009). The FANC pathway and BLM collaborate
during mitosis to prevent micro-nucleation and chromosome abnormal-
ities. Nat. Cell Biol. 11, 761–768.
16. Kawabata, T., Luebben, S.W., Yamaguchi, S., Ilves, I., Matise, I., Buske,
T., Botchan, M.R., and Shima, N. (2011). Stalled fork rescue via dormant
replication origins in unchallenged S phase promotes proper chromosome
segregation and tumor suppression. Mol. Cell 41, 543–553.
17. Weddington, N., Stuy, A., Hiratani, I., Ryba, T., Yokochi, T., and Gilbert,
D.M. (2008). ReplicationDomain: a visualization tool and comparative
database for genome-wide replication timing data. BMC Bioinformatics
9, 530.
18. Curtis, C., Shah, S.P., Chin, S.F., Turashvili, G., Rueda, O.M., Dunning,
M.J., Speed, D., Lynch, A.G., Samarajiwa, S., Yuan, Y., et al.;
METABRIC Group (2012). The genomic and transcriptomic architecture
of 2,000 breast tumours reveals novel subgroups. Nature 486, 346–352.
19. Muntean, A.G., and Hess, J.L. (2012). The pathogenesis of mixed-lineage
leukemia. Annu. Rev. Pathol. 7, 283–301.
20. Costantino, L., Sotiriou, S.K., Rantala, J.K., Magin, S., Mladenov, E.,
Helleday, T., Haber, J.E., Iliakis, G., Kallioniemi, O.P., and Halazonetis,
T.D. (2014). Break-induced replication repair of damaged forks induces
genomic duplications in human cells. Science 343, 88–91.td All rights reserved
21. Letessier, A., Millot, G.A., Koundrioukoff, S., Lachage`s, A.M., Vogt, N.,
Hansen, R.S., Malfoy, B., Brison, O., and Debatisse, M. (2011). Cell-
type-specific replication initiation programs set fragility of the FRA3B frag-
ile site. Nature 470, 120–123.
22. Blow, J.J., and Gillespie, P.J. (2008). Replication licensing and cancer—a
fatal entanglement? Nat. Rev. Cancer 8, 799–806.
23. Martin, M.M., Ryan, M., Kim, R., Zakas, A.L., Fu, H., Lin, C.M., Reinhold,
W.C., Davis, S.R., Bilke, S., Liu, H., et al. (2011). Genome-wide depletion
of replication initiation events in highly transcribed regions. Genome Res.
21, 1822–1832.
24. Dellino, G.I., Cittaro, D., Piccioni, R., Luzi, L., Banfi, S., Segalla, S.,
Cesaroni, M., Mendoza-Maldonado, R., Giacca, M., and Pelicci, P.G.
(2013). Genome-wide mapping of human DNA-replication origins: levels
of transcription at ORC1 sites regulate origin selection and replication
timing. Genome Res. 23, 1–11.
25. Ozeri-Galai, E., Lebofsky, R., Rahat, A., Bester, A.C., Bensimon, A., and
Kerem, B. (2011). Failure of origin activation in response to fork stalling
leads to chromosomal instability at fragile sites. Mol. Cell 43, 122–131.
26. Bartkova, J., Horejsı´, Z., Koed, K., Kra¨mer, A., Tort, F., Zieger, K.,
Guldberg, P., Sehested, M., Nesland, J.M., Lukas, C., et al. (2005). DNA
damage response as a candidate anti-cancer barrier in early human
tumorigenesis. Nature 434, 864–870.
27. Gorgoulis, V.G., Vassiliou, L.V., Karakaidos, P., Zacharatos, P., Kotsinas,
A., Liloglou, T., Venere, M., Ditullio, R.A., Jr., Kastrinakis, N.G., Levy, B.,
et al. (2005). Activation of the DNA damage checkpoint and genomic insta-
bility in human precancerous lesions. Nature 434, 907–913.
28. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise,
C., Schurra, C., Garre’, M., Nuciforo, P.G., Bensimon, A., et al. (2006).Current Biology 25, 132Oncogene-induced senescence is a DNA damage response triggered
by DNA hyper-replication. Nature 444, 638–642.
29. Burrell, R.A., McClelland, S.E., Endesfelder, D., Groth, P., Weller, M.C.,
Shaikh, N., Domingo, E., Kanu, N., Dewhurst, S.M., Gronroos, E., et al.
(2013). Replication stress links structural and numerical cancer chromo-
somal instability. Nature 494, 492–496.
30. Hills, S.A., and Diffley, J.F.X. (2014). DNA replication and oncogene-
induced replicative stress. Curr. Biol. 24, R435–R444.
31. Casper, A.M., Nghiem, P., Arlt, M.F., and Glover, T.W. (2002). ATR regu-
lates fragile site stability. Cell 111, 779–789.
32. Durkin, S.G., and Glover, T.W. (2007). Chromosome fragile sites. Annu.
Rev. Genet. 41, 169–192.
33. Debatisse, M., Le Tallec, B., Letessier, A., Dutrillaux, B., and Brison, O.
(2012). Common fragile sites: mechanisms of instability revisited. Trends
Genet. 28, 22–32.
34. Ozeri-Galai, E., Bester, A.C., and Kerem, B. (2012). The complex basis un-
derlying common fragile site instability in cancer. Trends Genet. 28,
295–302.
35. Negrini, M., Felix, C.A., Martin, C., Lange, B.J., Nakamura, T., Canaani, E.,
and Croce, C.M. (1993). Potential topoisomerase II DNA-binding sites at
the breakpoints of a t(9;11) chromosome translocation in acute myeloid
leukemia. Cancer Res. 53, 4489–4492.
36. Accordi, B., Espina, V., Giordan, M., VanMeter, A., Milani, G., Galla, L.,
Ruzzene, M., Sciro, M., Trentin, L., De Maria, R., et al. (2010).
Functional protein network activation mapping reveals new potential mo-
lecular drug targets for poor prognosis pediatric BCP-ALL. PLoS ONE 5,
e13552.7–1333, May 18, 2015 ª2015 Elsevier Ltd All rights reserved 1333
